JAK2 and essential thrombocythemia: The JAK2-STAT5 signaling cascade activated by the acquired mutation JAK2V617F plays a pivotal role in the pathogenesis of multiple MPNs, such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis.